TUCSON, Ariz., Oct. 25, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a provider of instruments, reagents and services
for molecular profiling applications, today announced that it will report its financial results for the three and nine months ended
September 30, 2018 after the market close on Thursday, November 8. Management will also host a conference call with investors to
discuss financial results and provide a corporate update at 4:30pm Eastern Time.
Conference Call & Webcast Details
Date:
Thursday, November 8
Time:
4:30pm Eastern Time
Toll
Free:
800-458-4121
International: 323-794-2093
Conference ID: 5881694
Webcast:
http://public.viavid.com/index.php?id=131460
About HTG:
HTG is focused on next generation sequencing (NGS) based molecular profiling. The company’s proprietary
HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when
limited in amount. HTG’s customers use its technology to identify biomarkers important for precision medicine, to understand the
clinical relevance of these discoveries, and ultimately to identify treatment options. Our mission is to empower precision medicine
at the local level.
Contact:
Ashley R. Robinson
LifeSci Advisors, LLC
Phone: (617) 525-7754
Email: arr@lifesciadvisors.com
